Index 
 Föregående 
 Nästa 
 All text 
Förfarande : 2018/2775(RSP)
Dokumentgång i plenum
Dokumentgång : B8-0071/2019

Ingivna texter :

B8-0071/2019

Debatter :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Omröstningar :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Röstförklaringar

Antagna texter :

P8_TA(2019)0113

Debatter
Onsdagen den 13 februari 2019 - Strasbourg Reviderad upplaga

16.11. Användning av cannabis för medicinska ändamål (B8-0071/2019) (omröstning)
Anföranden på video
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Senaste uppdatering: 24 maj 2019Rättsligt meddelande - Integritetspolicy